CTGCT
  • en
    • si
  • About us
    • About CTGCT
    • Partners
    • CTGCT Days 2025
    • Publications
  • Job Openings
  • Products and Services
  • Learning Box
  • POSTS
    • Events
    • Articles
    • News
    • All posts
  • Get in touch

Gen Therapy

  • Events
  • Researchers
  • Cell therapy
  • Gen Therapy
  • Clinic study
  • Marketaccess
  • Regulation
  • CTGCT
  • Rodrigo Ortiz
5 November 2025 Event Date: 27 October 2025 do: 29 October 2025 •

CTGCT Takeaways from the World Orphan Drug Congress Europe 2025

CTGCT attended the World Orphan Drug Congress (WODC) Europe 2025 in Amsterdam from the 27th to the 29th of October, an event dedicated to strategies and partnerships in the orphan drug industry. There were ...

1000018186
  • ATMPs
  • Cell therapy
  • Gen Therapy
  • Business Model
  • Drug Discovery
  • Economics
  • Marketaccess
  • Regulation
  • CTGCT
  • Gregor Cuzak
10 October 2025

Academic developers for affordable medicines

CTGCT (Centre for the Technologies of Gene and Cell Therapy, at National institute of Chemistry, Ljubljana) has joined the statement to preserve the Hospital Exemption in the revised EU pharmaceutical legislation. The Joint Statement, ...

  • Articles
  • Clinicians
  • Pacients
  • Researchers
  • Gen Therapy
  • Research
  • CTGCT
  • NIC
  • Rodrigo Ortiz
25 September 2025

From Film Editing to RNA Editing: How RNA Trans-splicing Could Treat CTNNB1 Syndrome

Imagine you're in a movie editing studio, trying to fix a film with some corrupted scenes. The film is vital, as it plays a crucial role in the development and function of an entire ...

Trans Splicing Paper
  • Events
  • Clinicians
  • Pacients
  • Researchers
  • ATMPs
  • Cell therapy
  • Gen Therapy
  • Research
  • Charite Berlin
  • CTGCT
  • NIC
  • TUD
  • UCL
  • UMCUtrecht
  • Rodrigo Ortiz
4 July 2025 Event Date: 15 September 2025 do: 17 September 2025 •

CTGCT Days 2025 – 15th to 17th September, Ljubljana

REGISTER  to join us at CTGCT Days 2025! A 3-day event in Ljubljana, Slovenia, spotlighting breakthroughs in gene & cell therapies (GCT) and their clinical translation.

Cover Image Conference
  • Articles
  • Clinicians
  • Pacients
  • Researchers
  • Gen Therapy
  • Research
  • Rodrigo Ortiz
5 June 2025

Unraveling the Mysteries of NLRP3: A Key Player in Inflammation

In the complex world of cellular biology, proteins play a crucial role in maintaining our body's health and responding to threats. One such protein, NLRP3, is known for its ability to assemble the inflammasome ...

Nlrp3 Paper
  • Articles
  • Clinicians
  • Pacients
  • Researchers
  • Cell therapy
  • Gen Therapy
  • Laboratory
  • Research
  • CTGCT
  • NIC
  • Rodrigo Ortiz
3 June 2025

Harnessing Synthetic Biology for Innovative Medical Treatments

In the world of synthetic biology, scientists are pushing the boundaries of what's possible by designing proteins that can be controlled in specific ways. This review written by Tjaša Plaper, Urška Knez Štibler and ...

Synthetic biology Review
  • Events
  • Clinicians
  • Pacients
  • Researchers
  • ATMPs
  • Cell therapy
  • Gen Therapy
  • Business Model
  • Marketaccess
  • CTGCT
  • NIC
  • Gregor Cuzak
20 May 2025 Event Date: 1 May 2025 do: 31 May 2025 •

Posters at Krakovski nasip – Ljubljanica embankment

In May 2025, our Centre for the Technologies of Gene and Cell Therapy CTGCT) is participating in a poster exhibition on Krakovski nasip, as part of the Chemical Institute’s public presentation.

  • Articles
  • Events
  • Clinicians
  • Pacients
  • Researchers
  • Gen Therapy
  • Raziskave
  • CTGCT
  • NIC
  • Rodrigo Ortiz
8 April 2025 Event Date: 21 March 2025 do: 21 March 2025 •

CTGCT’s Role in the GeneH Project: Accelerating Gene Therapy Innovations

We are thrilled to announce our participation in the GeneH consortium, an ambitious project led by the University of Coimbra, and their GeneT project, colead by the Kemijski Inštitut with the CTGCT project, aimed ...

  • Events
  • Clinicians
  • Researchers
  • Gen Therapy
  • Research
  • CTGCT
  • Rodrigo Ortiz
12 March 2025 Event Date: 17 March 2025 • 14:00 do: 17 March 2025 • 15:00

Gene Therapy: Triumphs, Challenges, and Future Directions

Lecture by Luis Pereira de Almeida on the 17th of March at the Kemijski Inštitut

Luis Pereira Lecture March 2025
  • Articles
  • Clinicians
  • Researchers
  • ATMPs
  • Cell therapy
  • Gen Therapy
  • Manufacturing Process
  • Regulation
  • CTGCT
  • UMCUtrecht
  • Rodrigo Ortiz
5 March 2025

Navigating Viral Vector Production for Gene Therapy

This week we had the opportunity to listen to Ganesh Ramesh, a PhD candidate at the Viral Vector Production Center for Translation Immunology of UMC Utrecht, under the supervision of Dr. Zsolt Sebestyen. Here ...

Ctgct Scientific Talk March 2025
  • Articles
  • Pacients
  • ATMPs
  • Cell therapy
  • Gen Therapy
  • Business Model
  • Economics
  • Pre Clinical
  • Research
  • CTGCT
  • NIC
  • Rodrigo Ortiz
28 February 2025

How Patient Advocacy is Driving Breakthroughs to Treat CTNNB1 Syndrome

Imagine a world where a child’s genetic disorder, once considered untreatable, is finally on a path toward real solutions. For families affected by the CTNNB1 syndrome, that future is becoming a reality thanks to ...

Paving The Way Ctnnb1
  • Articles
  • Pacients
  • Researchers
  • Gen Therapy
  • Laboratory
  • Pre Clinical
  • Research
  • CTGCT
  • NIC
  • Rodrigo Ortiz
28 January 2025

The research on combining cytokines with pyroptosis is gaining widespread media coverage

Research on combining cytokines and pyroptosis for cancer therapy by Slovenian scientists has gained significant media recognition, including TV features, articles, and the honor of being named "Names of the Week".

Odmevi Sara N Iva

Posts pagination

1 2 3

Logo Foot

Center for the Technologies of Gene and Cell Therapies (CTGCT) is an infrastructure center  within the National Institute of Chemistry, Slovenia

Contact

  • +386 1 4760 335
  • info@ctgct.si
  • Hajdrihova 19, 1001 Ljubljana

Privacy policy

  • Cookies

Follow us

X Twitter Brands SolidX-twitter

LinkedIn

Bluesky Brands Solid Bluesky

Funding

 

Eu Logo

Ukri Logo

Ministry Logo

 

Project: 101059842 – CTGCT – HORIZON-WIDERA-2022

Co-funded by the European Union, this project has received funding from Horizon Europe (grant agreement No. 101059842) and UK Research and Innovation (UKRI) under the UK government’s Horizon Europe funding guarantee (grant number 10069462). Views and opinions expressed are of the author(s) only and do not necessarily reflect those of the European Union or the European Research Executive Agency (REA). Neither the European Commission nor the granting authority can be held responsible for them


CTGCT © 2025
Website production: Kreativna tovarna